A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate
**Background/Objectives:** This article compares the effectiveness of baricitinib (BARI) 4 mg (oral, Janus kinase [JAK] 1/2 inhibitor) versus other targeted synthetic/biologic disease-modifying antirheumatic drugs, in combination with methotrexate (MTX), in moderate-to-severe rheumatoid arthritis pa...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | http://jheor.scholasticahq.com/article/12273-a-network-meta-analysis-to-compare-effectiveness-of-baricitinib-and-other-treatments-in-rheumatoid-arthritis-patients-with-inadequate-response-to-methotrexate.pdf |